The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development von Pinato, D. J., Yen, C., Bettinger, D., Ramaswami, R., Arizumi, T., Ward, C., Pirisi, M., Burlone, M. E., Thimme, R., Kudo, M., Sharma, R.

Volltext

On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study von Howell, J., Pinato, D. J., Ramaswami, R., Bettinger, D., Arizumi, T., Ferrari, C., Yen, C., Gibbin, A., Burlone, M. E., Guaschino, G., Sellers, L., Black, J., Pirisi, M., Kudo, M., Thimme, R., Park, J.‐W., Sharma, R.

Volltext

Toxocara encephalitis presenting with autonomous nervous system involvement von Caldera, F., Burlone, M. E., Genchi, C., Pirisi, M., Bartoli, E.

Volltext

Identification of actionable mutations in circulating cell-free tumour DNA as a prognostic biomarker in hepatocellular carcinoma von Howell, J, Atkinson, S, PInato, D.J, Knapp, S, Ward, C, Minisini, R, Burlone, M, Leutner, M, Pirisi, M, Khan, S, Odenthal, M, Thursz, M, Sharma, R

Volltext

Interferon Alpha Concentrations in Blood and Peritoneal Fluid During Treatment for Hepatitis C von SMIRNE, C, MINISINI, R, BURLONE, M. E, CERIANI, E, CORLIANO, F, OCCHINO, G, PIRISI, M

Volltext

Integration of the Cancer-Related Pro-Inflammatory Response as a Stratifying Biomarker of Survival Benefit with Sorafenib in Hepatocellular Carcinoma von Howell, J, Pinato, D, Ramaswami, R, Arizumi, T, Ferrari, C, Gibbin, A, Burlone, M, Guaschino, G, Black, J, Sellers, L, Kudo, M, Pirisi, M, Sharma, R

Volltext

P300 changes in patients with chronic hepatitis C after novel antiviral agents therapy: Preliminary data von Gori, B., Vaghi, G., Strigaro, G., Pizzamiglio, C., Vinassa, A., Burlone, M., Minisini, R., Varrasi, C., Pirisi, M., Cantello, R.

Volltext

A multi-center comparative study of Atezolizumab plus Bevacivumab and Lenvatinib as primary systemic therapy for unresectable hepatocellular carcinoma (HCC): focus on thrombotic an... von Tizzani, M., Mazzarelli, C., Burlone, M., Carucci, P., Caviglia, G.P., Lisi, C., Canalis, C., Cesarini, L., Pirisi, M., Acquaviva, A., Rolle, E., Pochettino, P., Bencardino, K., Villa, F., Angiolillo, M., Scaldaferri, M., Castellana, E., Cattel, F., Airoldi, M., Saracco, G.M., Gaia, S.

Volltext

The Piedmont-Aosta Valley Oncology Network experience in locally advanced HCC with intrahepatic neoplastic portal vein thrombosis: Y90-radioembolization versus Sorafenib von Martelletti, C., Gesualdo, M., Carucci, P., Gaia, S., Burlone, M., Okolicsanyi, S., Grosso, M., Pirisi, M., Tabone, M.

Volltext

Truncated forms of HCV core protein localize in distinct subcellular compartments von Burlone, M, Minisini, R, Cerutti, A, Alaimo, E, Maillard, P, Budkowska, A, Pirisi, M

Volltext

OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB von Sacco, R., Ciruolo, M., Paolillo, R., Ramai, D., Tortora, R., Di, Costanzo G.G., Burlone, M., Pirisi, M., Federico, P., Daniele, B., Silletta, M., Gallo, P., Cocuzza, C., Russello, M., Cabibbo, G., Cesario, S., Masi, G., Marzi, L., Mega, A., Granito, A., Pieri, G., Giannini, E., Gadaleta-Caldarola, G., Dadduzio, V., Giordano, G., Giacomelli, L., Papa, S., Renzulli, M., Maida, M., Ghidini, M., Facciorusso, A.

Volltext

Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma von Manfredi, G.F., Fulgenzi, C.A.M., D'Alessio, A., Celsa, C., Stefanini, B., Cheon, J., Ang, C., Marron, T.U., Saeed, A., Wietharn, B., Pressiani, T., Pinter, M., Scheiner, B., Huang, Yi-Hsiang, Phen, S., Naqash, A. Rafeh, Piscaglia, F., Lin, R. Po-Ting, -yen Lin, C., Dalbeni, A., Vivaldi, C., Masi, G., Thimme, R., Vogel, A., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Galle, P.R., Kudo, M., Rimassa, L., Singal, A., Sharma, R., Cortellini, A., Jae Chon, H., Burlone, M., Pirisi, M., Pinato, D.J.

Volltext

666 OCCULT HBV INFECTION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA von Sala, L, Rossi, D, Caldera, F, Burlone, M, Cerri, M, Minisini, R, Falleti, E, Toniutto, P, Franzosi, L, Fabris, C, Gaidano, G, Pirisi, M

Volltext

[325] CALCINEURIN INHIBITORS MAY BE INVOLVED IN FIBROGENESIS VIA DIRECT, AUTOCRINE EFFECTS ON STELLATE CELLS, AS WELL AS VIA THE INDUCTION OF SECOND MESSENGERS FROM HEPATOCYTES von Grazioli, S, Minisini, R, Franzosi, L, Sala, L, Burlone, M, Fabris, C, Toniutto, P, Caldera, F, Pirisi, M

Volltext

FRI-081 - Identification of actionable mutations in circulating cell-free tumour DNA as a prognostic biomarker in hepatocellular carcinoma von Howell, J., Atkinson, S., PInato, D.J., Knapp, S., Ward, C., Minisini, R., Burlone, M., Leutner, M., Pirisi, M., Khan, S., Odenthal, M., Thursz, M., Sharma, R.

Volltext

Risk-stratified management of advanced hepatocellular carcinoma (HCC) von Pinato, D.J., Kaplan, D.E., Yen, C., Rimassa, L., Dominik, B., Pressiani, T., Thimme, R., Pirisi, M., Burlone, M., Arizumi, T., Kudo, M., Park, J.W., Taddei, T.H., Johnson, P., Sharma, R.

Volltext

THU-154 - Risk-stratified management of advanced hepatocellular carcinoma (HCC) von Pinato, D.J., Kaplan, D.E., Yen, C., Rimassa, L., Dominik, B., Pressiani, T., Thimme, R., Pirisi, M., Burlone, M., Arizumi, T., Kudo, M., Park, J.W., Taddei, T.H., Johnson, P., Sharma, R.

Volltext

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma von Manfredi, Giulia Francesca, Celsa, Ciro, John, Chloe, Jones, Charlotte, Acuti, Nicole, Scheiner, Bernhard, Fulgenzi, Claudia Angela Maria, Korolewicz, James, Pinter, Matthias, Gennari, Alessandra, Mauri, Francesco A, Pirisi, Mario, Minisini, Rosalba, Vincenzi, Federica, Burlone, Michela, Rigamonti, Cristina, Donadon, Matteo, Cabibbo, Giuseppe, D'Alessio, Antonio, Pinato, David James

Volltext

Integration of the cancer-related pro-inflammatory response as a stratifying biomarker of survival benefit with sorafenib in hepatocellular carcinoma von Howell, J, Pinato, D, Ramaswami, R, Arizumi, T, Ferrari, C, Gibbin, A, Burlone, M, Guaschino, G, Black, J, Sellers, L, Kudo, M, Pirisi, M, Sharma, R

Volltext

PS117 - Integration of the Cancer-Related Pro-Inflammatory Response as a Stratifying Biomarker of Survival Benefit with Sorafenib in Hepatocellular Carcinoma von Howell, J., Pinato, D., Ramaswami, R., Arizumi, T., Ferrari, C., Gibbin, A., Burlone, M., Guaschino, G., Black, J., Sellers, L., Kudo, M., Pirisi, M., Sharma, R.

Volltext